Modern vision on the problem of chronic heart failure in the older persons
https://doi.org/10.37586/2686-8636-1-2021-65-75
Abstract
Aim. To analyze the factors associated with the development of chronic heart failure (CHF) in older age and to evaluate possible approaches to managing outpatients.
Material and methods. The search for domestic and foreign publications in Russian and international systems (PubMed, eLibrary, Medscape, etc.) for the last 0.5–15 years has been carried out. The analysis includes articles from the peer-reviewed literature.
Results. During aging, a number of structural changes and changes at the cellular level occur in the cardiovascular system, predisposing to the development of myocardial dysfunction, which explains the variety of manifestations of heart failure and the prevalence of preserved left ventricular ejection fraction (LVEF). Involutional functional and morphological changes in organs and systems form multimorbidity and nonspecificity of clinical symptoms and signs. «Cross symptoms» of frailty and CHF often complicate the timely diagnosis of the heart failure. Medications used for the treatment of CHF in older and younger patients are similar, but when choosing a specific drug, caution should be exercised in the group of the most vulnerable patients: over the age of 85, in the first two weeks after discharge from the hospital and in the presence of frailty.
Conclusion. Based on the available results of studies, it is necessary to be alert of primary care physicians regarding the presence of CHF with preserved LVEF in older persons with multimorbidity and geriatric syndromes. The therapeutic strategy for CHF older patients is complex and involves an individualized approach, depending on the clinical situation.
About the Author
V. N. Larina
Pirogov National Research Medical University
Russian Federation
Russian Federation
Larina Vera N., professor, Head of the Department of Outpatient Therapy, Faculty of Medicine, Doctor of Medical Sciences, Associate Professor.
Moscow
References
1. World Health Organization: Adherence to long-term therapies, evidence for action. Geneva: 2003. 230 р. http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf
2. Broekhuizen K., Pothof A., de Craen A.J.M., Mooijaart S.P. Characteristics of Randomized Controlled Trials Designed for Elderly: A Systematic Review. PLoS ONE. 2015; 10(5): e0126709. https://doi.org/10.1371/journal.pone.0126709
3. Chang A.Y., Skirbekk V.F., Tyrovolas S., Kassebaum N.J., Dieleman J.L. Measuring population ageing: an analysis of the Global Burden of Disease Study 2017. Lancet Public Health. 2019 Mar; 4(3): e159-e167. DOI: 10.1016/S2468-2667(19)30019-2
4. Клинические рекомендации. Хроническая сердечная недостаточность. Категория взрослые. Год утверждения 2020.
5. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation. 2013; 127: e6–e245. DOI: 10.1161/CIR.0b013e31828124ad
6. van Riet E.E., Hoes A.W., Wagenaar K.P., Limburg A., Landman M.A., Rutten F.H. Epidemiology of heart failure: the prev-alence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail. 2016; 18(3): 242–52. DOI: 10.1002/ejhf.483
7. Vasan R., Xanthakis V., Lyass A., Andersson C., Tsao C., Cheng S., Aragam J., Benjamin E., Larson M. Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study. An Echocardiographic Study Over 3 Decades. JACC: Cardiovascular Imaging 2018; 1(11). DOI: 10.1016/j. jcmg.2017.08.007
8. Groenewegen A., Rutten F.H., Mosterd A., Hoes A.W. Epidemiology of heart failure. Eur J Heart Fail. 2020; 22(8): 1342– 1356. DOI: 10.1002/ejhf.1858
9. Roger V.L. Epidemiology of heart failure. Circ Res. 2013; 113: 646–659 doi.org/10.1161/CIRCRESAHA.113.300268
10. Koudstaal S., Pujades-Rodriguez M., Denaxas S., Gho JMIH, Shah A.D, Yu N., Patel R.S., Gale C.P., Hoes A.W., Cleland J.G., Asselbergs F.W., Hemingway H. Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people. Eur J Heart Fail. 2017 Sep; 19(9): 1119–1127. DOI: 10.1002/ejhf.709
11. K eller K.M., Howlett S.E. Sex Differences in the Biology and Pathology of the Aging Heart. Can J Cardiol. 2016. Sep; 32(9): 1065–73. DOI: 10.1016/j.cjca.2016.03.017
12. Steinmann E., Rocca H., Maeder M., Kaufman B., Pfisterer M., Rickenbacher P. Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction? European Journal of Internal Medicine 2018; 57: 61–69. DOI: 10.1016/j.ejim.2018.06.005
13. Larina V.N., Bart B.Y., Karpenko D.G., Starostin I.V., Larin V.G., Kulbachinskaya O.M. Polymorbidity and its association with the unfavorable course of chronic heart failure in outpatients aged 60 years and older. Kardiologiia. 2019; 59(12S): 25–36. (In Russ.) https://doi.org/10.18087/cardio.n431
14. Mareev V.Yu., Fomin I.V., Ageev F.T., Begrambekova Yu.L., Vasyuk Yu.A., Garganeeva A.A., Gendlin G.E., Glezer M.G., Gautier S.V., Dovzhenko T.V., Kobalava Z.D., Koziolova N.A., Koroteev A.V., Mareev Yu.V., Ovchinnikov A.G., Perepech N.B., Tarlovskaya E.I., Chesnikova A.I., Shevchenko A.O., Arutyunov G.P., Belenkov Yu.N., Galyavich A.S., Gilyarevsky S.R., Drapkina O.M., Duplyakov D.V., Lopatin Yu.M., Sitnikova M.Yu., Skibitsky V.V., Shlyakhto E.V. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treat-ment. Kardiologiia. 2018; 58(6S): 8–158. (In Russ.) https://doi.org/10.18087/cardio.2475
15. C onrad N., Judge A., Tran J., Mohseni H., Hedgecott D., Crespillo A.P., Allison M., Hemingway H., Cleland J.G., McMurray J.J.V., Rahimi K. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million indi-viduals. Lancet. 2018; 10; 391(10120): 572–580. DOI: 10.1016/S0140–6736(17)32520–5
16. Galeeva Z.M., Galyavich A.S., Baleeva L.V., Galimzyanova L.A., Rafikov A.Y., Gizatullina N.F., Mustafina D.A. The Case of Amyloidosis in Cardiological Practice. Kardiologiia. 2019; 59(1): 93–96. (In Russ.) https://doi.org/10.18087/cardio.2019.1.10221
17. Gendlin G.E., Emelina E.I., Kovaleva A.I., Nikitin I.G. Management of pa-tients with isolated aortic stenosis considering negative prognostic factors. Kardiologiia. 2017; 57(1S): 360–366. (In Russ.) https://doi.org/10.18087/cardio.2351
18. Poliakova A.A., Semernin E.N., Sitnikova M.Yu., Avagyan K.L., Grozov R.V., Pyko S.A., Krutikov A.N., Davydova V.G., Khmelnitskaya K.A., Shavloskii M.M., Korzhevskii D.E., Gudkova A.Y. Transthyretin amy-loidosis in a cohort of old and very old patients with chronic heart failure. Kardiologiia. 2018; 58(2S): 12–18. (In Russ.) https://doi.org/10.18087/cardio.2390
19. C offey S., Cairns B.J., Iung B. The modern epidemiol-ogy of heart valve disease. Heart. 2016; 102: 75–85. DOI: 10.1136/heartjnl-2014–307020
20. C hakos A., Wilson-Smith A., Arora S., Nguyen T.C., Dhoble A., Tarantini G., Thielmann M., Vavalle J.P., Wendt D., Yan T.D., Tian D.H. Long term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyond. Ann Cardiothorac Surg. 2017; 6(5): 432–443. DOI: 10.21037/acs.2017.09.10
21. Ageev F.T., Danielyan M.O., Mareev V.Y. et al. Patients with chronic heart fail-ure in the Russian ambulatory practice: contingent features, diagnosis and treatment (studies of AGE-O-CHF). Russian Heart Failure Journal. 2004; 5(1): 4–7.]
22. Shah S., Kitzman D., Borlaug B., Heerebeek L., Zile M., Kass D., Paulus W. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap. Circulation 2016; 134: 73–90. DOI: 10.1161/CIRCULATIONAHA.116.021884;
23. Reddy Y., Carter R., Obokata M., Redfield M., Borlaug B. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction. Circulation. 2018; 138(9): 861–870. DOI: 10.1161/CIRCULATIONAHA.118.034646
24. Frolova E.V. The clinical features of heart failure in elderly and oldage. Kardiologiia. 2018; 58(8S): 4–11. (In Russ.) https://doi.org/10.18087/cardio.2487
25. Parikh K.S., Sharma K., Fiuzat M., Surks H.K., George J.T., Honarpour N., Depre C., Desvigne-Nickens P., Nkulikiyinka R., Lewis G.D., Gomberg-Maitland M., O'Connor C.M., Stockbridge N., Califf R.M., Konstam M.A., Januzzi J.L. Jr, Solomon S.D., Borlaug B.A., Shah S.J., Redfield M.M., Felker G.M. Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Trials. JACC Heart Fail. 2018; 6(8): 619–632. DOI: 10.1016/j.jchf.2018.06.008
26. Tromp J., Khan M.A., Klip I.T., Meyer S., de Boer R.A., Jaarsma T., Hillege H., van Veldhuisen D.J., van der Meer P., Voors A.A. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction. J Am Heart Assoc. 2017; 30; 6(4): e003989. DOI: 10.1161/JAHA.116.003989
27. Senni M., Paulus W.J., Gavazzi A., Fraser A.G., Díez J., Solomon S.D., Smiseth O.A., Guazzi M., Lam C.S., Maggioni A.P., Tschöpe C., Metra M., Hummel S.L., Edelmann F., Ambrosio G., Stewart Coats A.J., Filippatos G.S., Gheorghiade M., Anker S.D., Levy D., Pfeffer M.A., Stough W.G., Pieske B.M. New strategies for heart failure with preserved ejection fraction: the importance of tar-geted therapies for heart failure phenotypes. Eur Heart J. 2014; 21; 35(40): 2797–815. DOI: 10.1093/eurheartj/ehu204
28. Peiscke P., Tschope C., de Boer R., Fraser A. Anker S. et al. How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC), European Heart Journal. 2019; 40 (40): 3297– 3317. https://doi.org/10.1093/eurheartj/ehz641
29. Sueta D., Yamamoto E., Nishihara T., Tokitsu T., Fujisue K., Oike F. et al. H2FPEF Score as a Prognostic Value in HFpEF Patients, American Journal of Hypertension. 2019; 32 (11): 1082– 1090. https://doi.org/10.1093/ajh/hpz108
30. Mareev Yu.V., Garga neeva A.A., Tukish O.V., Rebrova T.Yu., Anikina D.V., Mareev V.Yu. Difficulties in diagnosis of heart failure with pre-served ejection fraction in clinical practice: dissonance between echocardiography, NTproBNP and H2HFPEF score. Kardiologiia. 2019; 59(12S): 37–45. (In Russ.). https://doi.org/10.18087/cardio.n695
31. Dodson J., Chaudhry S. Geriatric conditions in heart fail-ure. Curr Cardiovasc Risk Rep 2012; 6(5): 404–410. DOI: 10.1007/s12170–012–0259–8
32. Ткачева О.Н. и др. Ведение пациентов со старческой астенией в первичном звене здравоохранения: учебное пособие для врачей. Москва: Издательство РАМН, 2016. 56с.
33. Haykowsky M.J., Timmons M.P., Kruger C., McNeely M., Taylor D.A., Clark A.M. Meta-analysis of aerobic interval training on exercise capacity and systolic function in patients with heart failure and reduced ejection fractions. Am J Cardiol. 2013; 111(10): 1466–9. DOI: 10.1016/j.amjcard.2013.01.303
34. D enfeld Q.E., Winters-Stone K., Mudd J.O., Gelow J.M., Kurdi S., Lee C.S. The prevalence of frailty in heart failure: A system-atic review and meta-analysis. Int J Cardiol. 2017; 236: 283–289. DOI: 10.1016/j.ijcard.2017.01.153
35. B oxer R.S., Wang Z., Walsh S.J., Hager D., and Kenny A.M. (2008). The utility of the 6-minute walk test as a measure of frailty in older adults with heart failure. Am. J. Geriatr. Cardiol. 17, 7–12. DOI: 10.1111/j.1076–7460.2007.06457.x
36. U chmanowicz I., Nessler J., Gobbens R., Gackowski A., Kurpas D., Straburzynska-Migaj E., Kałuzna-Oleksy M., Jankowska E.A. Coexisting Frailty With Heart Failure. Front Physiol. 2019. Jul 3; 10: 791. DOI: 10.3389/fphys.2019.00791
37. N adruz W., Kitzman D., Windham B.G., Kucharska-Newton A., Butler K., Palta P., et al. (2017). Cardiovascular dysfunc-tion and frailty among older adults in the community: the ARIC Study. J. Gerontol. A Biol. Sci. Med. Sci. 72, 958–964. DOI: 10.1093/gerona/glw199
38. Felker M., Mann D., Flaherty J., Bonow R. Heart Failure as a Consequence of Ischemic Heart Disease. In: Felker M, Mann D, eds. Heart Failure: A Companion to Braunwald’s Heart Disease. 4th edition. Philadelphia, United States: Elsevier; 2019: 254–268
39. Tkacheva O.N., Belenkov Yu.N., Karpov Yu.A., Zyryanov S.K. Gerontology Issues in Cardiology Practice.Kardiologiia. 2019; 59(12): 54–63. (In Russ.). https://doi.org/10.18087/cardio.2019.12.n876
40. Rahi B., Colombet Z., Gonzalez-Colaço Harmand M. et al. Higher Protein but Not Energy Intake Is Associated With a Lower Prevalence of Frailty Among Community-Dwelling Older Adults in the French Three-City Cohort. J Am Med Dir Assoc. 2016; 17(7): 672.e7–672.e11. DOI: 10.1016/j.jamda.2016.05.005
41. Бойцов С.А., Погосова Н.В., Бубнова М.Г., Драпкина О.М., Гаврилова Н.Е., Еганян Р.А., Калинина А.М., Карамнова Н.С., Кобалава Ж.Д., Концевая А.В., Кухарчук В.В., Лукьянов М.М., Масленникова Г.Я., Марцевич С.Ю., Метельска я В.А., Мешк ов А.Н., Оганов Р.Г., Попович М.В., Соколова О.Ю., Сухарева О.Ю., Ткачева О.Н., Шальнова С.А., Шестакова М.В., Юферева Ю.М., Явелов И.С. Кардиоваскулярная профилактика 2017. Российские национальные рекомендации. Российский кардиологический журнал 2018; 23 (6): 7–122. DOI:10.15829/1560–4071–2018–6-7–122
42. R ossello X., Dorresteijn J.A., Janssen A., Lambrinou E., Scherrenberg M. et al. Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). European Journal of Preventive Cardiology. 2019; 26(14): 1534–1544. https://doi.org/10.1177/2047487319846715.
43. Orl ova Ya.A., Tkacheva O.N., Arutyunov G.P., Kotovskaya Yu.V., Lopatin Yu.M., Mareev V.Yu. et al. Features of di-agnostics and treatment of chronic heart failure in elderly and senile patients. Expert opinion of the Society of Experts in Heart Failure, Russian Association of Gerontologists, and Euroasian Association of Therapists. Kardiologiia. 2018; 58(S12): 42–72. DOI: 10.18087/cardio.256
44. D uque E.R., Briasoulis A., Alvarez P.A. Heart failure with preserved ejection fraction in the elderly: pathophysiology, diagnos-tic and therapeutic approach. J Geriatr Cardiol. 2019 May; 16(5): 421–428. DOI: 10.11909/j.issn.1671–5411.2019.05.009
45. Laribi S., Aouba A., Nikolaou M., Lassus J., Cohen-Solal A., Plaisance P., Pavillon G., Jois P., Fonarow G.C., Jougla E., Mebazaa A. GREAT Network. Trends in death attributed to heart failure over the past two decades in Europe. Eur J Heart Fail 2012; 14: 234–239. doi.org/10.1093/eurjhf/hfr182
46. Katsanos S. et al. Acute heart failure syndromes in the elderly: the European perspective. Heart Fail Clin. 2015; 11: 637–645. DOI: 10.1016/j.hfc.2015.07.010
Review
For citations:
Larina V.N. Modern vision on the problem of chronic heart failure in the older persons. Russian Journal of Geriatric Medicine. 2021;(1):65-75. (In Russ.) https://doi.org/10.37586/2686-8636-1-2021-65-75
Views:
788
Email this article 